title: Unresolved questions about the most successful known parasite.
abstract: Every 3 years, the International Congress on Congenital Toxoplasmosis meeting gathers experts with different backgrounds who are involved in congenital toxoplasmosis: gynecologists, pediatricians, ophthalmologists, microbiologists, epidemiologists and research scientists. Most attendees come from the Americas and Europe, where substantial work has been performed to better understand this disease. Two presentations that stressed major current issues in the field of toxoplasmosis are summarized here.
authors.affiliation: Laboratoire de Parasitologie-Mycologie, EA 3174-NETEC, Faculté de Médecine, Université de Limoges, Limoges, 87025, France. ajz@unilim.fr
authors.forename: Daniel
authors.initials: D
authors.lastname: Ajzenberg
mesh_terms: D000818:Animals; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007391:International Cooperation; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy* / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control; D011295:Prenatal Care; D011739:Pyrimethamine / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013020:South America / Q000453:epidemiology; D015572:Spiramycin / Q000008:administration & dosage / Q000627:therapeutic use*; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use; D014122:Toxoplasma / Q000187:drug effects; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy* / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology / Q000503:physiopathology
chemical_list: D013411:Sulfadiazine; D015572:Spiramycin; D011739:Pyrimethamine